-
Basu A, Meyer K, Ray R B. Hepatitis C virus core protein modulates the interferon-indued transacting factors of Jak/stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene[J]. Virology, 2001, 288(): 379-390. doi: 10.1006/viro.2001.1100
-
Bisceglie D A. Hepatits C and hepatocellular car-cinoma[J]. Hepatology, 1997, 26(): 34S-38S. doi: 10.1002/(ISSN)1527-3350
-
Ciccaglione A R, Stellacci E, Marcantonio C. Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes[J]. J Virol, 2007, 81(): 202-214. doi: 10.1128/JVI.01011-06
-
Foy E, Li K, Wang C. Regulation of interferon regulartory factor-3 by the hepatitis C virus serine protease[J]. Science, 2003, 300(): 1145-1148. doi: 10.1126/science.1082604
-
Fried M W, Shiffman M L, Reddy K R. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med, 2002, 347(): 975-982. doi: 10.1056/NEJMoa020047
-
Gale M, Blakely C M, Kwieciszewski B. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation[J]. Mol Cell Biol, 1998, 18(): 5208-5218. doi: 10.1128/MCB.18.9.5208
-
Kisseleva T, Bhattacharya S, Braunstein J. Signaling through the JAK/STAT pathway, recent advances and future challenges[J]. Gene, 2002, 285(): 1-24. doi: 10.1016/S0378-1119(02)00398-0
-
Lee C H, Choi Y H, Yang S H. Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages[J]. Virology, 2001, 279(): 271-279. doi: 10.1006/viro.2000.0694
-
Naganuma A, Nozaki A, Tanaka T. Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatits C virus core protein[J]. J Virol, 2000, 74(): 8744-8750. doi: 10.1128/JVI.74.18.8744-8750.2000
-
Ohkawa K, Ishida H, Nakanishi F. Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression[J]. J Biol Chem, 2004, 279(): 11719-11726. doi: 10.1074/jbc.M308560200
-
Ruggieri A, Murdolo M, Harada T. Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing Hepatitis C virus core protein[J]. Arch Virol, 2004, 149(): 61-74.
-
Starr R, Willson T A, Viney E M. A family of cytokine-inducible inhibitors of signaling[J]. Nature, 1997, 387(): 917-921. doi: 10.1038/43206
-
Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited[J]. Nat Rev Mol Cell Biol, 2001, 2(): 378-386. doi: 10.1038/35073080
-
Taylor D, Shi S, Romano P. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein[J]. Science, 1999, 285(): 107-110. doi: 10.1126/science.285.5424.107
-
Walsh M J, Jonsson J R, Richardson M M. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1[J]. Gut, 2006, 55(): 529-35. doi: 10.1136/gut.2005.069674
-
Zhu H Z, Nelson D R, Crawford J M. Defective Jak-stat activation in hepatoma cells is asso-ciated with hepatitis C viral IFN-α resistance[J]. J In-terferon Cytokine Res, 2005, 25(): 528-539. doi: 10.1089/jir.2005.25.528